Journal of Clinical Investigation · 2006 · 614 citations · 39 references
MedicineCancer BiologyOncologyMetastasisTumor MicroenvironmentVaccinologyCancer ImmunotherapyCancer VaccinesCancer-associated FibroblastsImmunotherapy For Breast CancerImmunotherapy For Solid TumorsTumor Microenvironment ModulationCancer Dna VaccinesCancer-associated Fibroblast TargetingDeoxyribonucleic Acid (Dna) VaccineDna Cancer VaccinesFibroblast ActivationOral Vaccine FormulationsT Cell-mediated Tumor KillingTherapeutic Cancer Immunization
Tumor-associated fibroblasts are key regulators of tumorigenesis. In contrast to tumor cells, which are genetically unstable and mutate frequently, the presence of genetically more stable fibroblasts in the tumor-stromal compartment makes them an optimal target for cancer immunotherapy. These cells are also the primary source of collagen type I, which contributes to decreased chemotherapeutic drug uptake in tumors and plays a significant role in regulating tumor sensitivity to a variety of chemotherapies. To specifically kill tumor-associated fibroblasts, we constructed an oral DNA vaccine targeting fibroblast activation protein (FAP), which is specifically overexpressed by fibroblasts in the tumor stroma. Through CD8+ T cell-mediated killing of tumor-associated fibroblasts, our vaccine successfully suppressed primary tumor cell growth and metastasis of multidrug-resistant murine colon and breast carcinoma. Furthermore, tumor tissue of FAP-vaccinated mice revealed markedly decreased collagen type I expression and up to 70% greater uptake of chemotherapeutic drugs. Most importantly, pFap-vaccinated mice treated with chemotherapy showed a 3-fold prolongation in lifespan and marked suppression of tumor growth, with 50% of the animals completely rejecting a tumor cell challenge. This strategy opens a new venue for the combination of immuno- and chemotherapies.
39
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Thomas Boehm, Judah Folkman, Timothy Browder et al. · Nature · 1997 · 1.7K citations
Medicine, Oncology, Pharmacology +16
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Neil A. Bhowmick, Anna Chytil, David Plieth et al. · Science · 2004 · 1.4K citations
Transport of molecules in the tumor interstitium: a review.
PubMed · 1987 · 1.4K citations
Medicine, Cancer Biology, Oncology +17
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Paolo A. Netti, David A. Berk, Melody A. Swartz et al. · PubMed · 2000 · 1.2K citations · Full text